6.0003
Abeona Therapeutics Inc Aktie (ABEO) Neueste Nachrichten
SEC Form DEFA14A filed by Abeona Therapeutics Inc. - Quantisnow
Abeona Therapeutics® Announces Date of First Quarter Financial Results - The Manila Times
Abeona sets May 13 investor call on Q1 results and company progress - Stock Titan
2,000,000 Shares in Abeona Therapeutics Inc. $ABEO Purchased by AIGH Capital Management LLC - MarketBeat
Eight new Abeona hires get stock awards that vest over 3 years - Stock Titan
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - ChartMill
AIGH, Orin Hirschman disclose 3.1M ABEO shares (ABEO) - Stock Titan
Abeona Therapeutics (NASDAQ:ABEO) Share Price Crosses Above 50 Day Moving AverageHere's What Happened - MarketBeat
[ARS] ABEONA THERAPEUTICS INC. SEC Filing - Stock Titan
Abeona Therapeutics (NASDAQ: ABEO) sets 2026 virtual meeting on directors, pay and equity plan - Stock Titan
(ABEO) Risk Channels and Responsive Allocation - Stock Traders Daily
Abeona (ABEO) Competitive Advantages | Abeona Therapeutics 2% EPS miss, $5.82M revenueRevenue Growth Rate - Xã Vĩnh Công
ABEO Should I Buy - Intellectia AI
Spotlighting Abeona Therapeutics And 2 More High Growth Stocks Insiders Favor - Yahoo Finance
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2025 earnings call transcript - MSN
Abeona Therapeutics (NASDAQ: ABEO) asks shareholders to approve 3.1M extra equity shares - Stock Titan
Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a Potential 262% Upside in Biotechnology - DirectorsTalk Interviews
(ABEO) Movement as an Input in Quant Signal Sets - Stock Traders Daily
ABEO SEC FilingsAbeona Therapeut 10-K, 10-Q, 8-K Forms - Stock Titan
JPMorgan Chase Trims Stake in Abeona Therapeutics - National Today
Abeona Therapeutics Stock Price Crosses 50-Day Moving Average - National Today
JPMorgan Chase & Co. Trims Position in Abeona Therapeutics Inc. $ABEO - MarketBeat
Abeona Therapeutics (NASDAQ:ABEO) Stock Price Crosses Above 50 Day Moving AverageHere's Why - MarketBeat
Aberdeen Group Invests $3.25M in Abeona Therapeutics - National Today
Aberdeen Group plc Makes New $3.25 Million Investment in Abeona Therapeutics Inc. $ABEO - MarketBeat
Abeona Therapeutics Inc. (NASDAQ:ABEO) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Abeona Therapeutics Adds Keith Goldan to Board, Audit Chair - The Globe and Mail
Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors - Sahm
Abeona Therapeutics names Keith Goldan to board of directors By Investing.com - Investing.com Canada
Abeona Therapeutics Inc. (ABEO) stock price, news, quote and history - Yahoo Finance UK
Abeona Therapeutics names Keith Goldan to board of directors - Investing.com
Abeona Therapeutics Announces Appointment of Keith A. Goldan to its Board of Directors - Bitget
Abeona Therapeutics Appoints Keith A. Goldan to Board - National Today
Abeona Therapeutics Appoints Keith A. Goldan to Board of Directors and Audit Committee to Support Commercial Growth - Minichart
[Form 4] ABEONA THERAPEUTICS INC. Insider Trading Activity - Stock Titan
Abeona Therapeutics (ABEO) director Form 3 lists no stock trades - Stock Titan
Keith A. Goldan appointed to Abeona Therapeutics' board, named Audit Committee Chair - TradingView — Track All Markets
Keith Goldan joins Abeona Therapeutics (ABEO) board as independent audit chair - Stock Titan
Biotech Abeona taps veteran CFO Keith Goldan to oversee audits - Stock Titan
Abeona Therapeutics (ABEO) — 3.01M shares disclosed by Funicular/Cable Car (5.3%) - Stock Titan
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bitget
Four new Abeona hires get stock awards vesting over 3 years - Stock Titan
Panic Selling: Should I set a stop loss on Abeona Therapeutics Inc2026 Chart Watch & Detailed Earnings Play Alerts - baoquankhu1.vn
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York - Sahm
ABEO PE Ratio & Valuation, Is ABEO Overvalued - Intellectia AI
Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a 327% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
ABEO Technical Analysis & Stock Price Forecast - Intellectia AI
Abeona Therapeutics CEO Seshadri Vishwas sells $131k in stock By Investing.com - Investing.com Australia
Insider Sell: Vishwas Seshadri Sells 29,985 Shares of Abeona The - GuruFocus
Abeona Therapeutics CEO Seshadri Vishwas sells $131k in stock - Investing.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):